Comparison between Beta Drugs IPO and Siddharth Education IPO.
Beta Drugs IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Siddharth Education IPO is a SME Bookbuilding proposed to list at BSE SME.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Siddharth Education IPO is up to ₹10.33 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Siddharth Education IPO is ₹35.00 per share.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹30.00 per share | |
| Issue Price (Upper) | ₹35.00 per share | |
| Issue Price (Final) | ₹85.00 per share | ₹35.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 21,66,400 shares | 29,52,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹10.33 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 29,52,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹10.33 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Siddharth Education IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Siddharth Education IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 12, 2017 | Oct 12, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Siddharth Education IPO P/E ratio of .
| Beta Drugs IPO | Siddharth Education IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹73.52 Cr. | ₹40.60 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Siddharth Education IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in Siddharth Education IPO.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,29,600 shares | 1,56,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 14,76,000 shares |
| RII | 10,83,200 shares | 14,76,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 29,52,000 shares |
Beta Drugs IPO subscribed 18.97x in total, whereas Siddharth Education IPO subscribed 1.35x.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 29.93x | 1.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.00x | 0.84x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.97x | 1.35x |
